ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 60 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,000 | – | 1,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FNY Managed Accounts LLC | 7,500 | $127,000 | 1.28% |
| DLD Asset Management, LP | 485,900 | $8,250,000 | 1.07% |
| DLD Asset Management, LP | 364,300 | $6,186,000 | 0.81% |
| Sio Capital Management, LLC | 70,300 | $1,193,000 | 0.57% |
| Granite Point Capital Management, L.P. | 135,200 | $2,294,000 | 0.57% |
| Perceptive Advisors | 100,000 | $10,164,000 | 0.51% |
| Worth Venture Partners, LLC | 61,600 | $394,000 | 0.34% |
| Worth Venture Partners, LLC | 46,600 | $229,000 | 0.20% |
| Fiduciary Trust Co International of Pennsylvania | 139,450 | $2,366,000 | 0.12% |
| ROTHSCHILD INVESTMENT LLC /IL | 57,070 | $968,000 | 0.11% |